Myocardial infarction test kit

cTnIcreatine kinaseserum

5 tests/box, 25 tests/box, 40 tests/box, 100 tests/box Certificates: CE, SGS ISO13485, ISO9001 Matching Equipments: Solid Phase Fluorescence Immunoassay System Manufactured by Guangzhou KOFA Biotechnology Co.,Ltd. Intended Use: This reagent kit is base on fluorescent chromatographic technology, supporting the quantitative rapid test of cTnI/CK-MB level in the serum/plasma. The combined testing of cTnI/CK-MB is used to diagnose myocardial injury and infarction. The advantages of KOFA 2 In 1 (cTnI/ CK-MB): 1. Advanced fluoroimmunoassay quantitative testing platform, make accurate and quantitative rapid test of cTnI/CK-MB level available 2. Low cost and rapid test, can get the quantitative and reliable results in 15 minutes, shorten the testing turnaround time. 3. The testing results from KOFA cTnI/CK-MB has good correlation with that of Roche Diagnostics (compared with thousands of samples). 4. Simple operation and rapid test, can meet the need of various departments. 5. The combined testing of cTnI and CK-MB is more convenient, accurate and efficient than single testing items, making the patients well-treated in the shorter time. Applicable Departments: Departments of cardiology, surgery, geriatrics, respiratory, pediatrics, obstetrics, emergency ward and ICU.